D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
BIIB holding history
Biogen Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BIIB overviewAll 13F holders of BIIBFull Q2 2026 holdings
- Shares (Q2 2026)
- 74,438
- Value
- $16.1M
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 74,438 | $16.1M | <0.1% | +74,438 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −53,754−100.0% | Sold out | Holders |
| Q4 2025 | 53,754 | $9.46M | <0.1% | −424,170−88.8% | Reduced | Holders |
| Q3 2025 | 477,924 | $66.9M | 0.1% | −888,283−65.0% | Reduced | Holders |
| Q2 2025 | 1,366,207 | $171.6M | 0.2% | −219,365−13.8% | Reduced | Holders |
| Q1 2025 | 1,585,572 | $217.0M | 0.3% | −24,327−1.5% | Reduced | Holders |
| Q4 2024 | 1,609,899 | $246.2M | 0.3% | +1,174,960+270.1% | Added | Holders |
| Q3 2024 | 434,939 | $84.3M | 0.1% | +220,248+102.6% | Added | Holders |
| Q2 2024 | 214,691 | $49.8M | 0.1% | −85,317−28.4% | Reduced | Holders |
| Q1 2024 | 300,008 | $64.7M | 0.1% | +276,073+1,153.4% | Added | Holders |
| Q4 2023 | 23,935 | $6.19M | <0.1% | −254,903−91.4% | Reduced | Holders |
| Q3 2023 | 278,838 | $71.7M | 0.1% | −567,606−67.1% | Reduced | Holders |
| Q2 2023 | 846,444 | $241.1M | 0.4% | −487,546−36.5% | Reduced | Holders |
| Q1 2023 | 1,333,990 | $370.9M | 0.6% | −422,092−24.0% | Reduced | Holders |
| Q4 2022 | 1,756,082 | $486.3M | 0.8% | +220,767+14.4% | Added | Holders |
| Q3 2022 | 1,535,315 | $409.9M | 0.7% | +179,461+13.2% | Added | Holders |
| Q2 2022 | 1,355,854 | $276.5M | 0.4% | +361,974+36.4% | Added | Holders |
| Q1 2022 | 993,880 | $209.3M | 0.3% | +396,919+66.5% | Added | Holders |
| Q4 2021 | 596,961 | $143.2M | 0.2% | +220,470+58.6% | Added | Holders |
| Q3 2021 | 376,491 | $106.5M | 0.1% | −413,202−52.3% | Reduced | Holders |
| Q2 2021 | 789,693 | $273.4M | 0.3% | +180,453+29.6% | Added | Holders |
| Q1 2021 | 609,240 | $170.4M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.